GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
2

21st North ULGX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About 21st North

Its shares trade under the ticker ULGX. It has been listed since 30 May 1996. In the fiscal year to 30 June 2014, it reported revenue of $14.2m and a net loss of $7.6m. At that date it held total assets of $5.7m and shareholders' equity of −$7.0m.

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company is headquartered in Minneapolis, Minnesota. The firm offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm has no operations. The firm intends to dissolve.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
30 May 1996
Employees
61

Leadership

Pay as last reported

  • Mr. Mitchell DannIndependent Non-Executive Chairman of the Board, Lead Director, since 1991$55,846
  • Mr. Gregory FluetChief Executive Officer, Director, since 2008$231,246
  • Scott MadsonChief Financial Officer
  • Lisa AckermannExecutive Vice President - Sales and Marketing$241,964
  • Christopher BarysIndependent Director
  • Mr. Sidney EmeryIndependent Director
  • Mr. Patrick SpanglerIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • 21st North Inc has several strengths that contribute to its success in the market. These strengths include:

Weaknesses

  • Despite its strengths, 21st North Inc also has weaknesses that need to be addressed in order to maintain a competitive edge:

Opportunities

  • 21st North Inc can capitalize on various opportunities to expand its business and increase its market share:

Threats

  • There are certain threats that 21st North Inc needs to monitor and address to minimize their impact on the business:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.